New paper entitled “Spray-dried pneumococcal membrane vesicles are promising candidates for pulmonary immunization” published in the International Journal of Pharmaceutics. This collaborative work spearheaded by experts from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University explores optimized vaccine microparticles with a mean particle size of 1–2 µm, corrugated surface, and nanocrystalline nature.